BridgeBio Pharma (BBIO) Stock
BridgeBio Pharma (BBIO) closed at $76.80 on Nov 17, 2026; its Tenet Score is 43 of 100 against 340 Healthcare peers.
32 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $76.80
- Nov 17, 2026
- Market cap
- $15.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 62.50 – 93.42
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 43/100
- Weak · 340 Healthcare peers
Industry: Health Services
BridgeBio Pharma Inc scores 43/100. Weak. Quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 43 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage developmen…
Similar-sized companies in Health Services
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Revvity Inc.RVTY | 43 | $16.6B |
| Charles River Laboratories International Inc.CRL | 33 | $16.1B |
| Icon PlcICLR | 42 | $14.7B |
| Glaukos CorporationGKOS | 43 | $14.5B |
| Encompass Health CorpEHC | 55 | $13.9B |
| Smith & Nephew plcSNN | 61 | $13.6B |
| Baxter International Inc.BAX | 37 | $13.2B |
| Penumbra IncPEN | 57 | $12.6B |
| Fresenius Medical Care AGFMS | 44 | $12.2B |
| Molina Healthcare IncMOH | 41 | $12.2B |
Common questions
What sector and industry is BridgeBio Pharma in?
BridgeBio Pharma is in the Healthcare sector and the Health Services industry.
What is BridgeBio Pharma's Tenet Score?
BridgeBio Pharma's Tenet Score is 43 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




